Cargando…

Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More

Detalles Bibliográficos
Autor principal:	Kim, Young Dae
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053561/ https://www.ncbi.nlm.nih.gov/pubmed/21430989 http://dx.doi.org/10.4070/kcj.2011.41.2.58

Ejemplares similares

Nitric oxide and pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2017)

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017)

When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
por: Niedermeyer, Shannon, et al.
Publicado: (2023)

Nitric oxide and pulmonary hypertension
por: Sim, Ji-Yeon
Publicado: (2010)

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
por: Tettey, Abraham, et al.
Publicado: (2021)

Welcome to PathoGenetics
por: Ballabio, Andrea, et al.
Publicado: (2008)

Pulmonary Hypertension: More To Be Done
por: Idrees, Majdy M
Publicado: (2009)

Unravelling the Pathogenetic Mechanisms in Congenital Aortopathies: Need for an Integrative Translational Approach
por: Girdauskas, Evaldas, et al.
Publicado: (2020)

Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways
por: Mandras, Stacy, et al.
Publicado: (2021)

An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension
por: Liu, Yiwei, et al.
Publicado: (2022)

Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION
por: Cascino, Thomas M., et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension: More options, more awareness
por: Allwood, B W, et al.
Publicado: (2023)

Food for Thought: The Emerging Role of Intestinal Microbiota in Pulmonary Arterial Hypertension
por: Aldred, Micheala A.
Publicado: (2022)

Influence of nitric oxide signaling mechanisms in cancer
por: Ramírez-Patiño, R, et al.
Publicado: (2022)

Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension
por: Tanaka, Mariko, et al.
Publicado: (2017)

Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
por: Malekmohammad, Majid, et al.
Publicado: (2019)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension
por: Agarwal, Stuti, et al.
Publicado: (2021)

Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators
por: Di Chiara, Tiziana, et al.
Publicado: (2022)

More welcome data on pulmonary hypertension in South Africa
por: Raine, Richard
Publicado: (2021)

Nitric oxide
por: Yang, Zhi-Lu, et al.
Publicado: (2019)

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension
por: Malhotra, Rajeev, et al.
Publicado: (2011)

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension
por: Barst, Robyn J., et al.
Publicado: (2012)

Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
por: Malekmohammad, Majid, et al.
Publicado: (2019)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
por: Kumar, Shine, et al.
Publicado: (2022)

Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension
por: Hinton, Martha, et al.
Publicado: (2023)

Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges
por: Costagliola, Giorgio, et al.
Publicado: (2023)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy
por: Tonelli, Adriano R., et al.
Publicado: (2013)

Nitric Oxide-Sensitive Pulmonary Hypertension in Congenital Rubella Syndrome
por: Raimondi, Francesco, et al.
Publicado: (2015)

Molecular Regulatory Mechanisms Drive Emergent Pathogenetic Properties of Neisseria gonorrhoeae
por: Sunkavalli, Ashwini, et al.
Publicado: (2022)

New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity
por: Yoo, Byung Won
Publicado: (2018)

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis
por: van Duin, Richard W. B., et al.
Publicado: (2019)

A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
por: Stene Hurtsén, Anna, et al.
Publicado: (2020)

Nitric oxide: emerging implications for headache mechanics
por: Zicari, Alessandra, et al.
Publicado: (2001)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b084gprrjcjg8ul7jdb6e3blkn